These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22497939)

  • 1. Neuroimaging: a scanner, colourfully.
    Roiser JP; Rees G
    Curr Biol; 2012 Apr; 22(7):R231-3. PubMed ID: 22497939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.
    Carhart-Harris RL; Leech R; Williams TM; Erritzoe D; Abbasi N; Bargiotas T; Hobden P; Sharp DJ; Evans J; Feilding A; Wise RG; Nutt DJ
    Br J Psychiatry; 2012 Mar; 200(3):238-44. PubMed ID: 22282432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.
    Carhart-Harris RL; Erritzoe D; Williams T; Stone JM; Reed LJ; Colasanti A; Tyacke RJ; Leech R; Malizia AL; Murphy K; Hobden P; Evans J; Feilding A; Wise RG; Nutt DJ
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2138-43. PubMed ID: 22308440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.
    Spain A; Howarth C; Khrapitchev AA; Sharp T; Sibson NR; Martin C
    Neuropharmacology; 2015 Dec; 99():210-20. PubMed ID: 26192543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced repertoire of brain dynamical states during the psychedelic experience.
    Tagliazucchi E; Carhart-Harris R; Leech R; Nutt D; Chialvo DR
    Hum Brain Mapp; 2014 Nov; 35(11):5442-56. PubMed ID: 24989126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain.
    Müller F; Liechti ME; Lang UE; Borgwardt S
    Prog Brain Res; 2018; 242():159-177. PubMed ID: 30471679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased low-frequency brain responses to music after psilocybin therapy for depression.
    Wall MB; Lam C; Ertl N; Kaelen M; Roseman L; Nutt DJ; Carhart-Harris RL
    J Affect Disord; 2023 Jul; 333():321-330. PubMed ID: 37094657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.
    Roseman L; Demetriou L; Wall MB; Nutt DJ; Carhart-Harris RL
    Neuropharmacology; 2018 Nov; 142():263-269. PubMed ID: 29288686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment.
    Turton S; Nutt DJ; Carhart-Harris RL
    Curr Drug Abuse Rev; 2014; 7(2):117-27. PubMed ID: 25563444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.
    Gill H; Puramat P; Patel P; Gill B; Marks CA; Rodrigues NB; Castle D; Cha DS; Mansur RB; Rosenblat JD; McIntyre RS
    Psychiatry Res; 2022 Jul; 313():114577. PubMed ID: 35580433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.
    Mertens LJ; Wall MB; Roseman L; Demetriou L; Nutt DJ; Carhart-Harris RL
    J Psychopharmacol; 2020 Feb; 34(2):167-180. PubMed ID: 31941394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.
    Barrett FS; Krimmel SR; Griffiths RR; Seminowicz DA; Mathur BN
    Neuroimage; 2020 Sep; 218():116980. PubMed ID: 32454209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psilocybin: A brief overview for psychiatric mental health nurse practitioners.
    Fradkin D
    Perspect Psychiatr Care; 2022 Jul; 58(3):1200-1203. PubMed ID: 34101846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.
    Rosenblat JD; Leon-Carlyle M; Ali S; Husain MI; McIntyre RS
    Am J Psychiatry; 2023 May; 180(5):395-396. PubMed ID: 36945824
    [No Abstract]   [Full Text] [Related]  

  • 17. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
    Pearson C; Siegel J; Gold JA
    J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.
    McCulloch DE; Madsen MK; Stenbæk DS; Kristiansen S; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    J Psychopharmacol; 2022 Jan; 36(1):74-84. PubMed ID: 34189985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.
    Agin-Liebes G; Davis AK
    Curr Top Behav Neurosci; 2022; 56():125-140. PubMed ID: 34811715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.
    Lebedev AV; Lövdén M; Rosenthal G; Feilding A; Nutt DJ; Carhart-Harris RL
    Hum Brain Mapp; 2015 Aug; 36(8):3137-53. PubMed ID: 26010878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.